Breast Cancer Treatment Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type Of Breast Cancer (Invasive, Non-Invasive (in Situ)), By Diagnosis (Blood Tests, Mammogram, Breast MRI, Breast Ultrasound, Breast Biopsy, Others), By Treatment (Breast Cancer Surgery, Radiation Therapy, Chemotherapy, Hormone Therapy, Targeted Therapy, Supportive/ Palliative Care), And By Geography - Forecasts From 2019 To 2024
- Published : May 2021
- Report Code : KSI061612326
- Pages : 129
The breast cancer treatment market is projected to grow at a CAGR of 3.01% to reach US$15.82 billion by 2024. The breast cancer treatment market is expected to grow at a moderate pace during the forecast period due to the worldwide prevalence of breast cancer. The main reasons for the disease include the consumption of alcohol and greater birth weight. The growing adoption of unhealthy lifestyle conditions among women of different age groups is leading to higher incidences of cancer during the forecast period. Breast cancer survival rates vary greatly worldwide, ranging from 80% or more in the North American region, Sweden and Japan to around 60% in the middle-income countries and below 40% in low-income countries (Source: WHO). Growing awareness regarding self-care and self-management, technological advancements, and R&D expenditure is further driving the market growth during the forecast period. Currently, available treatment includes medications, therapy devices, and technologies in addition to palliative or supportive care. However, the high cost of treatment may restrain the market growth during the forecast period.
Major industry players profiled as part of the report are Novartis AG, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb, AbbVie Inc., AstraZeneca, Orbital Therapy, Cianna Medical, Inc., IntraOp Medical Corporation, iCAD, Inc., and IceCure Medical, Inc.
Breast Cancer Treatment Market Scope:
|Market size value in 2024||US$15.82 billion|
|Growth Rate||CAGR of 3.01% from 2018 to 2024|
|Forecast Unit (Value)||USD Billion|
|Segments covered||Type, Diagnosis, Treatment, And Geography|
|Regions covered||North America, South America, Europe, Middle East and Africa, Asia Pacific|
|Companies covered||Novartis AG, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb, AbbVie Inc., AstraZeneca, Orbital Therapy, Cianna Medical, Inc., IntraOp Medical Corporation, iCAD, Inc., IceCure Medical, Inc.|
|Customization scope||Free report customization with purchase|
The breast cancer treatment market has been analyzed through the following segments:
• By Type of Breast Cancer
o Non-Invasive (in situ)
• By Diagnosis
o Blood Tests
o Breast MRI
o Breast Ultrasound
o Breast Biopsy
• By Treatment
o Breast Cancer Surgery
o Radiation Therapy
o ‘Hormone Therapy
o Targeted Therapy
o Supportive/ Palliative Care
• By Geography
o North America
o South America
o United Kingdom
o Middle East and Africa
o Saudi Arabia
o Asia Pacific
o South Korea
Frequently Asked Questions (FAQs)
Q1. What will be the breast cancer treatment market size by 2024?
A1. The breast cancer treatment market is projected to reach a total market size of US$15.82 billion in 2024.
Q2. What are the growth prospects for breast cancer treatment market?
A2. Breast Cancer Treatment market is projected to grow at a CAGR of 3.01% over the forecast period.
Q3. Who are the major players in global breast cancer treatment market?
A3. Major industry players profiled as part of the breast cancer treatment market report are Novartis AG, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb, AbbVie Inc., AstraZeneca, Orbital Therapy, Cianna Medical, Inc., IntraOp Medical Corporation, iCAD, Inc., and IceCure Medical, Inc.
Q4. What factors are anticipated to drive the breast cancer treatment market growth?
A4. The breast cancer treatment market is expected to grow at a moderate pace during the forecast period due to the worldwide prevalence of breast cancer.
Q5. How is the global breast cancer treatment market segmented?
A5. The breast cancer treatment market has been segmented based on the type of breast cancer, diagnosis, treatment, and geography.
2. RESEARCH METHODOLOGY
3. KEY FINDINGS
4. MARKET DYNAMICS
4.1. Market Overview and Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5.1. By age group
4.5.2. By region
4.6. Product Pipeline
5. BREAST CANCER TREATMENT MARKET BY TYPE OF BREAST CANCER
5.2. Non-Invasive (in situ)
6. BREAST CANCER TREATMENT MARKET BY DIAGNOSIS
6.1. Blood Tests
6.3. Breast MRI
6.4. Breast Ultrasound
6.5. Breast Biopsy
7. BREAST CANCER TREATMENT MARKET BY TREATMENT
7.1. Breast Cancer Surgery
7.2. Radiation Therapy
7.4. Hormone Therapy
7.5. Targeted Therapy
7.6. Supportive/ Palliative Care
8. BREAST CANCER TREATMENT MARKET BY GEOGRAPHY
8.1. North America
8.2. South America
8.3.3. United Kingdom
8.4. Middle East and Africa
8.4.1. Saudi Arabia
8.5. Asia Pacific
8.5.3. South Korea
9. COMPETITIVE INTELLIGENCE
9.1. Competitive Benchmarking and Analysis
9.2. Recent Investments and Deals
9.3. Strategies of Key Players
10. COMPANY PROFILES
10.1. Novartis AG
10.2. F. Hoffmann-La Roche Ltd
10.3. Bristol-Myers Squibb 10.3.1. Overview
10.4. AbbVie Inc.
10.6. Orbital Therapy
10.7. Cianna Medical, Inc.
10.8. IntraOp Medical Corporation
10.9. iCAD, Inc.
10.10. IceCure Medical, Inc.
LIST OF FIGURES
LIST OF TABLES
F. Hoffmann-La Roche Ltd
Cianna Medical, Inc.
IntraOp Medical Corporation
IceCure Medical, Inc.
|Report Name||Published Month||Get Sample PDF|
|Cancer Diagnostics Market Size & Share: Industry Report, 2023-2028||Sep 2023|
|Global Cancer Biomarkers Market Size & Share: 2019 - 2024||Mar 2021|
|Breast Imaging Market Size & Share: Industry Report, 2022 – 2027||Aug 2022|
|Breast Pump Market Size & Share: Industry Report, 2022–2027||Sep 2022|
|Breast Reconstruction Market Size: Industry Report, 2022–2027||Aug 2022|